GMP IPO Watch
1. Live Status: Subscription Update (March 26, 12:30 PM)
The IPO has seen a steady build-up in interest over the last 48 hours. As of mid-day Day 3:
Total Subscription: Approximately 4.48x to 5.2x.
Retail Portion: This is the most active segment, currently oversubscribed by over 6.2x.
NII (HNI) Interest: Showing robust demand at nearly 6.5x.
Grey Market (GMP): The GMP is currently trading around ₹20, suggesting a potential listing price of ₹140 (a 16.6% premium over the issue price).
2. The Business: Specialized "Eyes" for Industry
Highness Microelectronics doesn't just make screens; they make displays that survive where others fail.
Vertical Integration: They design, develop, and assemble digital imaging solutions, moving away from simple trading to high-value engineered products.
Key Segments: * Defense & Aerospace: Now their largest segment (contributing ~45% of H1FY26 revenue), providing rugged displays for harsh environments.
Railways: Major projects including display systems for DMRC (Delhi Metro).
Healthcare: Specialized medical-grade monitors.
Export Shift: Historically domestic-heavy, the company has successfully increased its export share to nearly 48% in the first half of FY26.
3. IPO Snapshot & Timeline
| Event / Detail | Important Dates & Info |
|---|---|
| IPO Closing Date | Friday, March 27, 2026 |
| Price Band | ₹114 to ₹120 per share |
| Lot Size | 1,200 Shares |
| Retail Min. Investment | ₹2,88,000 (2 Lots) |
| Allotment Date | Monday, March 30, 2026 |
| Listing Date | Thursday, April 2, 2026 (BSE SME) |
4. Financial Highlights: Growth on Display
The company’s financial trajectory shows significant scaling:
Revenue: Grew from ₹9.91 crore (FY23) to ₹14.41 crore in just the first 9 months of FY26.
Profitability (PAT): Witnessed a massive jump from ₹0.44 crore (FY23) to ₹3.41 crore (Dec 2025).
Valuation: At the upper band, the P/E ratio is ~13.6x, which is notably lower than the sector average of ~17x to 45x, suggesting the issue is attractively priced for investors.
5. The Verdict: Strengths & Risks
The Bull Case (The "Pros"):
Niche Technology: Very few Indian SMEs operate in the specialized ruggedized display market with ISO 13485 (Medical) certifications.
Order Book: Strong visibility with ~₹10 crore in confirmed orders as of late 2025, including high-profile Metro projects.
Efficiency: Excellent return ratios with ROE at 47% and ROCE at 42%, showing very efficient use of capital.
The Bear Case (The "Cons"):
Import Dependency: High reliance on China for raw materials/components makes them vulnerable to supply chain shocks or geopolitical shifts.
High Entry Cost: Being an SME IPO, the minimum ticket size of ₹2.88 lakh is high for smaller retail participants.
Employee Attrition: The company has noted high turnover in recent years, which can impact technical R&D continuity.
